Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Starpharma Shares Report

Abstract:
The Board of Starpharma Holdings Limited (Starpharma or Company) advises that the Company has today settled the placement of 11,853,844 fully paid ordinary shares in Starpharma at a share price of A$0.26 (Shares), to institutional, sophisticated and professional investors, as announced on 7 April 2009.

Starpharma Shares Report

Melbourne, Australia | Posted on April 8th, 2009

The Shares were issued without disclosure to investors under Part 6D.2 of the Corporations Act 2001 (Corporations Act). Starpharma provides this notice in accordance with section 708A(5)(e) of the Corporations Act.

Starpharma notifies ASX (as operator of the prescribed financial market on which the ordinary shares are or are to be quoted) that, as at the date of this notice, Starpharma has complied with the provisions of Chapter 2M of the Corporations Act (as they apply to Starpharma), and with section 674 of the Corporations Act.

As at the date of this notice, Starpharma is not in possession of any excluded information within the meaning of sections 708A(7) and 708A(8) of the Corporations Act.

####

About Starpharma Holdings Limited
Starpharma is a world leader in the development of nanotechnology-based pharmaceuticals and, through its US-based subsidiary Dendritic Nanotechnologies (DNT), a range of life-science and industrial uses.

Starpharma is listed on the Australian Securities Exchange (ASX: SPL)and its securities also trade in the US under the American Depository Receipts (ADR) program (OTCQX: SPHRY).

For more information, please click here

Contacts:
General Enquiries


Investor Relations

Copyright © Starpharma Holdings Limited

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Nano Ruffles in Brain Matter: Freiburg researchers decipher the role of nanostructures around brain cells in central nervous system function October 31st, 2014

Gold nanoparticle chains confine light to the nanoscale October 31st, 2014

'Nanomotor lithography' answers call for affordable, simpler device manufacturing October 31st, 2014

Device invented at Johns Hopkins provides up-close look at cancer on the move: Microscopic view of metastasis could give insight about how to keep cancer in check October 31st, 2014

Announcements

Nano Ruffles in Brain Matter: Freiburg researchers decipher the role of nanostructures around brain cells in central nervous system function October 31st, 2014

Gold nanoparticle chains confine light to the nanoscale October 31st, 2014

'Nanomotor lithography' answers call for affordable, simpler device manufacturing October 31st, 2014

Device invented at Johns Hopkins provides up-close look at cancer on the move: Microscopic view of metastasis could give insight about how to keep cancer in check October 31st, 2014

Financial Reports

Aspen Aerogels, Inc. Schedules Third Quarter 2014 Earnings Release and Conference Call for November 6, 2014 October 17th, 2014

Nanometrics to Announce Third Quarter Financial Results on October 28, 2014 October 8th, 2014

Harris & Harris Group Letter to Shareholders on Website August 19th, 2014

Arrowhead Reports Fiscal 2014 Third Quarter Financial Results and Provides Update on ARC-520 August 12th, 2014

NanoNews-Digest
The latest news from around the world, FREE





  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE